APL1, an altered peptide ligand derived from human heat-shock protein 60, increases the frequency of Tregs and its suppressive capacity against antigen responding effector CD4 + T cells from rheumatoid arthritis patients
about
APL1, an altered peptide ligand derived from human heat-shock protein 60, increases the frequency of Tregs and its suppressive capacity against antigen responding effector CD4 + T cells from rheumatoid arthritis patients
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 30 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
APL1, an altered peptide ligan ...... rheumatoid arthritis patients
@en
APL1, an altered peptide ligan ...... rheumatoid arthritis patients.
@nl
type
label
APL1, an altered peptide ligan ...... rheumatoid arthritis patients
@en
APL1, an altered peptide ligan ...... rheumatoid arthritis patients.
@nl
prefLabel
APL1, an altered peptide ligan ...... rheumatoid arthritis patients
@en
APL1, an altered peptide ligan ...... rheumatoid arthritis patients.
@nl
P2093
P2860
P1476
APL1, an altered peptide ligan ...... rheumatoid arthritis patients
@en
P2093
Ariana Barberá
Dinorah Prada
Femke Broere
Gabriel Padrón
Joel van Roon
Jorge Gómez
María Del Carmen Domínguez
Noraylis Lorenzo
Peter van Kooten
Wilco de Jager
P2860
P2888
P304
P356
10.1007/S12192-016-0698-0
P577
2016-05-30T00:00:00Z